Javier Narbona

发表

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

L. Álvarez-Vallina, P. Chames, C. Corbacho, 2022, Oncoimmunology.

A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin

J. Tomé-Amat, J. Lacadena, Javier Narbona, 2023, Cancers.

Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment

L. Sanz, J. Lacadena, Javier Narbona, 2023, Biomolecules.

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses

L. Álvarez-Vallina, M. Compte, L. Sanz, 2024, Oncoimmunology.